SSc-Systemic Sclerosis: Clinical Trials

1 trial for SSc-Systemic Sclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow SSc-Systemic Sclerosis: new trials by email Literature Review of SSc-Systemic Sclerosis trials Research Report on SSc-Systemic Sclerosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
QT-019C - SLE - Systemic Lupus Erythematosus, SSc-Systemic Sclerosis
Phase 1RecruitingInstitute of Hematology & Blood Diseases Hospital, China122026-01-012026-01-20

Narrower conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Lupus Erythematosus, Systemic (1)

Broader conditions

Autoimmune Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Connective Tissue Diseases (1)  ·  Immune System Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Vascular (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Systemic Vasculitis (1)  ·  Vascular Diseases (1)  ·  Vasculitis (1)

Sponsors

Institute of Hematology & Blood Diseases Hospital, China (1)

Countries

China (1)